News and Events
Our latest news
Our News
Glycovax Pharma, the National Research Council of Canada and the Université de Montréal, join forces to develop an innovative vaccine against the bacterium Pseudomonas aeruginosa (Pa), made possible through CQDM’s financial support
Our News
CQDM, IVADO, and two Quebec-based companies join forces to accelerate the diagnosis of pancreatic neuroendocrine tumors using artificial intelligence
Events
Sweet pharma day
Programs
Our main financing opportunities
Our members
Extensive Expertise and Essential Support
CQDM members bring together key players focused on innovation, collaboration, and strengthening the biopharmaceutical sector. CQDM offers three types of membership. We invite you to explore them and find the one that best aligns with your goals and needs.
- “Network” Member
- “Project” Member
- “Pharmaceutical” Member
